DEA investigators on April 27 said Evergreen Park Pharmacy was suspended from dispensing schedule II-V controlled pharmaceutical medicines after its investigation and a subsequent Illinois Prescription Monitoring Program review found the pharmacy allegedly dispensed “excessive opioids and dangerous drug combinations” to multiple patients.
The administration said a pharmacy expert review of dispensing records for three patients concluded “the quantities and combinations of controlled substance medications dispensed to these patients were not for legitimate medical purposes and could have led to respiratory failure and death.”
“If a pharmacy fails to maintain regulated professional standards when dispensing controlled substances, and continued dispensing authority would be inconsistent with the public interest, the DEA may administratively suspend and ultimately revoke the pharmacy’s registration,” investigators said in their announcement, adding the suspension order only alleges violations and gives registrants the right to administrative hearings.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
